From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research
Bruce K. CasselsDepartment of Chemistry, Faculty of Sciences, University of Chile, Casilla 653, Santiago, Chile. [email protected]Isabel BermúdezSchool of Biological and Molecular Sciences, Oxford Brookes University, Gipsy Lane, Oxford OX3 0BP, UKFederico DajasInstituto de Investigaciones Biológicas Clemente Estable, Avenida Italia 3318, C.P. 11600 Montevideo, UruguayJuan Andrés Abin‐CarriquiryInstituto de Investigaciones Biológicas Clemente Estable, Avenida Italia 3318, C.P. 11600 Montevideo, UruguaySusan WonnacottDepartment of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK
2005en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба